Core Insights - Amesite, Inc. is participating in The Microcap Conference 2025, focusing on growth opportunities for companies and investors [1] - The CEO, Dr. Ann Marie Sastry, will present updates on the NurseMagic™ app and discuss growth strategies [2] - NurseMagic™ is an AI-powered mobile application aimed at enhancing the efficiency of nursing professionals and home health care workers [3][4] Company Overview - Amesite, Inc. specializes in B2C and B2B AI-driven solutions, leveraging proprietary AI infrastructure [4] - The NurseMagic™ app streamlines nursing documentation, improves patient communication, and provides personalized guidance for nurses [4]

Core Viewpoint - Amesite Inc. has successfully closed a public offering of 1,201,667 shares at a price of $3.00 per share, raising approximately $3.6 million, with participation from certain officers and directors totaling around $1.26 million [1][2]. Group 1: Offering Details - The public offering was underwritten on a "best efforts" basis, with Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC serving as joint book-running managers [2]. - The net proceeds from the offering will be allocated for general corporate purposes, capital expenditures, working capital, and general and administrative expenses [2]. Group 2: Company Overview - Amesite Inc. specializes in developing and marketing AI-driven solutions for both B2C and B2B markets, leveraging proprietary AI infrastructure [5]. - The company offers applications such as NurseMagic™, a mobile app designed for health and care professionals, which aids in nursing documentation, enhances patient communication, and provides personalized guidance [5]. Group 3: Regulatory Information - A shelf registration statement related to the public offering was filed with the SEC and declared effective on December 18, 2024 [3]. - A preliminary prospectus supplement and accompanying prospectus for the offering are available on the SEC's website [3].

Core Viewpoint - Amesite Inc. has announced a public offering of 1,201,667 shares at a price of $3.00 per share, aiming to raise approximately $3.6 million, with participation from certain officers and directors for about $1.26 million [1][2]. Group 1: Offering Details - The public offering is underwritten on a "best efforts" basis and is expected to close on January 8, 2025, pending customary closing conditions [1]. - Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC are serving as joint book-running managers for the offering [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for general corporate purposes, capital expenditures, working capital, and general and administrative expenses [2]. Group 3: Company Overview - Amesite Inc. specializes in AI-driven solutions for both B2C and B2B markets, leveraging proprietary AI infrastructure to develop applications that meet individual and professional needs [5]. - The company's mobile app, NurseMagic™, assists health and care professionals by streamlining nursing documentation, enhancing patient communication, and providing personalized guidance [5].

Core Viewpoint - Amesite Inc. intends to conduct a public offering of its common stock or pre-funded warrants, subject to market conditions, with no assurance on the timing or terms of the offering [1]. Group 1: Offering Details - The offering will be managed by Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC as joint book-running managers [2]. - The net proceeds from the offering will be utilized for general corporate purposes, capital expenditures, working capital, and general and administrative expenses [2]. - A shelf registration statement related to the public offering was filed with the SEC and declared effective on December 18, 2024 [3]. Group 2: Company Overview - Amesite Inc. specializes in developing and marketing AI-driven solutions for both B2C and B2B markets [5]. - The company offers applications that cater to individual and professional needs, including NurseMagic™, a mobile app designed for health and care professionals to streamline nursing documentation and enhance patient communication [5].

Core Insights - Amesite Inc. is set to present its growth strategy for NurseMagic, targeting both B2C and B2B users across 50 states and 21 countries, covering 87 professions [1][3][4] - The presentation will take place at the Sidoti January Virtual Investor Conference on January 22-23, 2025, with live access available through Amesite's website [2] Company Overview - Amesite Inc. specializes in AI-driven solutions for B2C and B2B markets, including a mobile app called NurseMagic that enhances healthcare professionals' efficiency [5] - NurseMagic supports a wide range of healthcare professionals, including registered nurses, physicians, EMTs, and healthcare executives, demonstrating significant user growth since its launch [3][5] Sales and Market Potential - The company has reported strong enterprise sales, particularly among franchisees of major home care providers, indicating a robust market response to NurseMagic [4] - Amesite's CEO highlighted the potential for sustainable revenue growth due to the efficiency improvements NurseMagic offers in healthcare settings [4]

Core Viewpoint - Amesite Inc. is set to release an end-of-year video shareholder update, highlighting its AI-driven solutions and the monetization of its NurseMagic™ application [1]. Group 1: Company Overview - Amesite Inc. specializes in developing and marketing B2C and B2B AI-driven solutions, leveraging proprietary AI infrastructure [3]. - The company’s mobile app, NurseMagic™, is designed for health and care professionals, facilitating nursing documentation, enhancing patient communication, and providing personalized guidance [3]. Group 2: Financial and Operational Metrics - The update will cover NurseMagic™'s marketing, onboarding, and projected profitability metrics, as well as the company's infrastructure and scalability for user growth [3].

Company Dramatically Increasing Its Reach and Engagement as It Scales B2C and B2B Sales with AI-First Solution in HealthcareDETROIT, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), creator of the AI-powered NurseMagic™ app, announces significant marketing growth alongside its enterprise and consumer sales success. NurseMagic™ harnesses advanced AI to provide intelligent, real-time support for caregivers, transforming how care is delivered and managed. By building B2B and B2C visibility in par ...

Core Insights - Amesite Inc. has secured contracts with franchise owners of nationally recognized brands, marking a significant milestone for its NurseMagic™ app, which addresses workforce performance and engagement challenges in the healthcare sector [1] - The home health care industry in the U.S. is projected to grow from $100 billion in 2024 to $176 billion by 2032, highlighting the increasing demand for innovative solutions like NurseMagic™ [2] Company Developments - NurseMagic™ has been recognized as a scalable solution for franchise businesses, providing immediate ROI without disrupting existing systems [1] - The app has received positive feedback from franchise owners, emphasizing its user-friendly interface and effectiveness in improving operational efficiency [3] - Amesite has achieved several milestones within five months of launching NurseMagic™, including offering a paid individual subscription and meeting HIPAA compliance for enterprise customers [4] Industry Context - Approximately 77% of home care clients in the U.S. are turned away due to workforce limitations, indicating a critical need for solutions that enhance workforce capabilities [2] - The demand for smart, technical solutions in the home health care industry is expected to intensify as the market expands significantly over the next decade [2]

DETROIT, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading technology company specializing in AI-driven solutions for B2C and B2B markets, announced today the company’s app, NurseMagic™, is now available for direct subscription purchases by consumers. NurseMagic™ has seen strong user growth since its launch this summer and now supports users from eighty-seven (87) professions (ranging from registered nurses, to physicians, EMTs, occupational therapists, hospital managers, healthcare C ...

[PART I – FINANCIAL INFORMATION](index=5&type=section&id=PART%20I%20%E2%80%93%20FINANCIAL%20INFORMATION) Unaudited Q3 2024 financial statements, management's analysis, and disclosures, noting net losses and going concern doubts - Amesite Inc. specializes in B2C and B2B AI-driven solutions, including a higher education platform and the NurseMagic™ mobile healthcare app[22](index=22&type=chunk) - The company has a history of net losses and negative cash flows, raising substantial doubt about its ability to continue as a going concern[27](index=27&type=chunk)[30](index=30&type=chunk) - Management plans to generate cash through financing transactions, such as common stock offerings, but these are not guaranteed[30](index=30&type=chunk) [ITEM 1. FINANCIAL STATEMENTS](index=5&type=section&id=ITEM%201.%20FINANCIAL%20STATEMENTS) Presents unaudited Q3 2024 and 2023 condensed financial statements, including balance sheets, operations, equity, cash flows, and notes - The financial statements are unaudited and prepared in accordance with GAAP and SEC requirements[23](index=23&type=chunk)[24](index=24&type=chunk) - Interim results are not necessarily indicative of results for a full year[24](index=24&type=chunk) [Condensed Balance Sheets (unaudited)](index=8&type=section&id=Condensed%20Balance%20Sheets%20(unaudited)) Balance sheets show slight decreases in total assets and equity, increased current liabilities, and a significant drop in cash from June to September 2024 Condensed Balance Sheet Highlights (Unaudited) | Metric | September 30, 2024 | June 30, 2024 | Change (Absolute) | Change (%) | | :-------------------------- | :----------------- | :------------ | :---------------- | :--------- | | Cash and cash equivalents | $1,434,753 | $2,071,016 | $(636,263) | -30.72% | | Total current assets | $2,496,774 | $2,604,565 | $(107,791) | -4.14% | | Total noncurrent assets | $739,336 | $709,612 | $29,724 | 4.19% | | Total assets | $3,236,110 | $3,314,177 | $(78,067) | -2.36% | | Total current liabilities | $843,003 | $798,465 | $44,538 | 5.58% | | Total stockholders' equity | $2,393,107 | $2,515,712 | $(122,605) | -4.87% | [Condensed Statements of Operations (unaudited)](index=9&type=section&id=Condensed%20Statements%20of%20Operations%20(unaudited)) Operations statements show a significant revenue decrease for Q3 2024, leading to a slightly higher net loss despite reduced operating expenses Condensed Statements of Operations Highlights (Unaudited) | Metric | Three Months Ended Sep 30, 2024 | Three Months Ended Sep 30, 2023 | Change (Absolute) | Change (%) | | :-------------------------- | :------------------------------ | :------------------------------ | :---------------- | :--------- | | Net Revenue | $11,250 | $63,333 | $(52,083) | -82.24% | | Total Operating Expenses | $938,594 | $1,013,323 | $(74,729) | -7.37% | | Loss from Operations | $(927,344) | $(949,990) | $22,646 | -2.38% | | Interest Income | $19,299 | $59,297 | $(39,998) | -67.46% | | Net Loss | $(908,045) | $(890,693) | $(17,352) | 1.95% | | Basic and diluted loss per share | $(0.34) | $(0.35) | $0.01 | -2.86% | | Weighted average shares outstanding | 2,707,275 | 2,542,440 | 164,835 | 6.48% | [Condensed Statements of Stockholders' Equity (unaudited)](index=10&type=section&id=Condensed%20Statements%20of%20Stockholders'%20Equity%20(unaudited)) Stockholders' equity decreased from July 1 to September 30, 2024, primarily due to net loss, partially offset by stock issuance and compensation - Total stockholders' equity decreased from **$2,515,712** on July 1, 2024, to **$2,393,107** on September 30, 2024[18](index=18&type=chunk) - Net loss of **$(908,045)** contributed to the decrease in equity[18](index=18&type=chunk) - Issuance of **250,000 common shares** for consulting services added **$720,000** to additional paid-in capital[18](index=18&type=chunk) - Stock-based compensation expense was **$65,440** for the quarter[18](index=18&type=chunk) [Condensed Statements of Cash Flows (unaudited)](index=11&type=section&id=Condensed%20Statements%20of%20Cash%20Flows%20(unaudited)) Cash flows show a net decrease in cash for Q3 2024, driven by operating and investing activities, including significant capitalized software investment Condensed Statements of Cash Flows Highlights (Unaudited) | Metric | Three Months Ended Sep 30, 2024 | Three Months Ended Sep 30, 2023 | Change (Absolute) | Change (%) | | :------------------------------------------ | :------------------------------ | :------------------------------ | :---------------- | :--------- | | Net cash used in operating activities | $(488,263) | $(658,779) | $170,516 | -25.88% | | Net cash used in investing activities | $(148,000) | $(65,200) | $(82,800) | 127.00% | | Net decrease in cash and cash equivalents | $(636,263) | $(723,979) | $87,716 | -12.11% | | Cash and cash equivalents - End of period | $1,434,753 | $4,636,682 | $(3,201,929) | -69.05% | [Notes to Condensed Financial Statements (unaudited)](index=12&type=section&id=Notes%20to%20Condensed%20Financial%20Statements%20(unaudited)) These notes detail business operations, accounting policies, and financial items, reiterating liquidity concerns and going concern uncertainty - Financial statements are prepared in accordance with GAAP and SEC requirements, with certain disclosures condensed or omitted[23](index=23&type=chunk)[25](index=25&type=chunk) - The company's ability to continue as a going concern is uncertain due to historical losses and negative cash flows[26](index=26&type=chunk)[27](index=27&type=chunk)[28](index=28&type=chunk)[30](index=30&type=chunk) [Note 1 - Nature of Business and Liquidity](index=12&type=section&id=Note%201%20-%20Nature%20of%20Business%20and%20Liquidity) Amesite Inc. develops AI-driven solutions but faces liquidity challenges, with ongoing net losses raising substantial doubt about its going concern ability - Amesite Inc. develops and markets B2C and B2B AI-driven solutions, including a higher education platform and the NurseMagic™ mobile healthcare app[22](index=22&type=chunk) - The company has a history of net losses and negative cash flows from operating activities since inception[27](index=27&type=chunk) - Management believes it may not have sufficient cash for planned operations for the next twelve months, raising substantial doubt about its going concern ability[28](index=28&type=chunk) [Note 2 - Significant Accounting Policies](index=12&type=section&id=Note%202%20-%20Significant%20Accounting%20Policies) This note outlines accounting principles, including basis of presentation, going concern, estimates, and policies for cash, property, software, revenue, and taxes [Basis of Presentation](index=12&type=section&id=Basis%20of%20Presentation) Condensed financial statements adhere to GAAP and SEC requirements, with interim results not necessarily indicative of full-year performance - Statements adhere to GAAP and SEC rules[23](index=23&type=chunk) - Interim results may not predict full-year outcomes[24](index=24&type=chunk) [Going Concern](index=12&type=section&id=Going%20Concern) The company's history of net losses and negative cash flows raises substantial doubt about its ability to continue as a going concern, with financing plans uncertain - History of net losses and negative operating cash flows[27](index=27&type=chunk) - Substantial doubt exists regarding the company's ability to continue as a going concern[30](index=30&type=chunk) - Management plans to seek financing, but success is not assured[30](index=30&type=chunk) [Use of Estimates](index=13&type=section&id=Use%20of%20Estimates) Financial statements rely on management's estimates and assumptions, and actual results may differ from these projections - Financial statements rely on management estimates and assumptions[31](index=31&type=chunk) - Actual results could vary from estimates[31](index=31&type=chunk) [Cash and Cash Equivalents](index=13&type=section&id=Cash%20and%20Cash%20Equivalents) Cash equivalents include short-term investments, with the company